Several studies have shown that incomplete activation of CD8+ T cells in the tumor draining lymph node (TDLNs) is due to the effect of the tumor on dendritic cells (DCs), which are thought to be the major cross-presenting APC, rather than on the T cells themselves [5, 8, 10, 14–16]. This evidence concerns the gene CD8A and neoplasm.